Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000899243-20-019839

Director acquired 104,487 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Borisy Alexis Director 2020-07-20 Conversion +104,487 104,487 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Borisy Alexis Director 2020-07-20 Conversion · Series C Convertible Preferred Stock −371,027 0 D: show line 2 in the form
Loading xslF345X03/doc4.xml…